Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 86Recurrence 14Neoplasms, Plasma Cell 14Lymphoma, Non-Hodgkin 9Lymphoma 7Leukemia, Plasma Cell 6Immunoglobulin Light-chain Amyloidosis 5Smoldering Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Primary Myelofibrosis 2POEMS Syndrome 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hodgkin Disease 2Hematologic Neoplasms 2Fasting 2Burkitt Lymphoma 2Alzheimer Disease 2Waldenstrom Macroglobulinemia 1Vomiting 1Vitamin D Deficiency 1Thrombocythemia, Essential 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Chromosome 17 deletion × Plasma cell × Clear all
NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Rutgers, The State University of New Jersey

Phase EARLY_PHASE1 Terminated
2 enrolled 6 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡